Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor

Eric Simpson, Arne Böhling, Stephan Bielfeldt, Catherine Bosc, Nabil Kerrouche

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background: Atopic dermatitis (AD) is characterized by barrier abnormalities, including insufficient ceramides in the stratum corneum (SC). Objective: To measure the effects of a new moisturizer (CRM) containing a ceramide precursor in improving skin barrier function in patients with controlled atopic dermatitis. Methods: In this randomized, intra-individual comparison, investigator-blinded study, CRM was applied to the test area of one lower leg for 27 days (the other leg remained as untreated control). Evaluations at baseline and day 28 included transepidermal water loss (TEWL), skin hydration by corneometry, dryness severity, Raman spectroscopy, and collection of adverse events. Results: After 4 weeks of treatment, results showed a significantly greater reduction of TEWL and clinical dryness scores, and increased skin hydration (all p <01) in the CRM-treated than untreated area. A significantly higher level of ceramide (p <05) and a trend toward increased water content was observed with Raman in the SC for CRM than for the control. There were no related AEs. Conclusion: Skin barrier function and hydration were significantly improved after CRM treatment.

Original languageEnglish (US)
Pages (from-to)122-125
Number of pages4
JournalJournal of Dermatological Treatment
Volume24
Issue number2
DOIs
StatePublished - Apr 2013

Fingerprint

Ceramides
Atopic Dermatitis
Skin
Cornea
Water
Leg
Raman Spectrum Analysis
Research Personnel
Therapeutics

Keywords

  • Atopic dermatitis
  • Ceramides
  • Raman spectroscopy
  • Skin barrier
  • Skin hydration
  • Transepidermal water loss

ASJC Scopus subject areas

  • Dermatology

Cite this

Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. / Simpson, Eric; Böhling, Arne; Bielfeldt, Stephan; Bosc, Catherine; Kerrouche, Nabil.

In: Journal of Dermatological Treatment, Vol. 24, No. 2, 04.2013, p. 122-125.

Research output: Contribution to journalArticle

Simpson, Eric ; Böhling, Arne ; Bielfeldt, Stephan ; Bosc, Catherine ; Kerrouche, Nabil. / Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. In: Journal of Dermatological Treatment. 2013 ; Vol. 24, No. 2. pp. 122-125.
@article{1b43ec90a04b41a2876cd6bedcbda1c5,
title = "Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor",
abstract = "Background: Atopic dermatitis (AD) is characterized by barrier abnormalities, including insufficient ceramides in the stratum corneum (SC). Objective: To measure the effects of a new moisturizer (CRM) containing a ceramide precursor in improving skin barrier function in patients with controlled atopic dermatitis. Methods: In this randomized, intra-individual comparison, investigator-blinded study, CRM was applied to the test area of one lower leg for 27 days (the other leg remained as untreated control). Evaluations at baseline and day 28 included transepidermal water loss (TEWL), skin hydration by corneometry, dryness severity, Raman spectroscopy, and collection of adverse events. Results: After 4 weeks of treatment, results showed a significantly greater reduction of TEWL and clinical dryness scores, and increased skin hydration (all p <01) in the CRM-treated than untreated area. A significantly higher level of ceramide (p <05) and a trend toward increased water content was observed with Raman in the SC for CRM than for the control. There were no related AEs. Conclusion: Skin barrier function and hydration were significantly improved after CRM treatment.",
keywords = "Atopic dermatitis, Ceramides, Raman spectroscopy, Skin barrier, Skin hydration, Transepidermal water loss",
author = "Eric Simpson and Arne B{\"o}hling and Stephan Bielfeldt and Catherine Bosc and Nabil Kerrouche",
year = "2013",
month = "4",
doi = "10.3109/09546634.2012.713461",
language = "English (US)",
volume = "24",
pages = "122--125",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor

AU - Simpson, Eric

AU - Böhling, Arne

AU - Bielfeldt, Stephan

AU - Bosc, Catherine

AU - Kerrouche, Nabil

PY - 2013/4

Y1 - 2013/4

N2 - Background: Atopic dermatitis (AD) is characterized by barrier abnormalities, including insufficient ceramides in the stratum corneum (SC). Objective: To measure the effects of a new moisturizer (CRM) containing a ceramide precursor in improving skin barrier function in patients with controlled atopic dermatitis. Methods: In this randomized, intra-individual comparison, investigator-blinded study, CRM was applied to the test area of one lower leg for 27 days (the other leg remained as untreated control). Evaluations at baseline and day 28 included transepidermal water loss (TEWL), skin hydration by corneometry, dryness severity, Raman spectroscopy, and collection of adverse events. Results: After 4 weeks of treatment, results showed a significantly greater reduction of TEWL and clinical dryness scores, and increased skin hydration (all p <01) in the CRM-treated than untreated area. A significantly higher level of ceramide (p <05) and a trend toward increased water content was observed with Raman in the SC for CRM than for the control. There were no related AEs. Conclusion: Skin barrier function and hydration were significantly improved after CRM treatment.

AB - Background: Atopic dermatitis (AD) is characterized by barrier abnormalities, including insufficient ceramides in the stratum corneum (SC). Objective: To measure the effects of a new moisturizer (CRM) containing a ceramide precursor in improving skin barrier function in patients with controlled atopic dermatitis. Methods: In this randomized, intra-individual comparison, investigator-blinded study, CRM was applied to the test area of one lower leg for 27 days (the other leg remained as untreated control). Evaluations at baseline and day 28 included transepidermal water loss (TEWL), skin hydration by corneometry, dryness severity, Raman spectroscopy, and collection of adverse events. Results: After 4 weeks of treatment, results showed a significantly greater reduction of TEWL and clinical dryness scores, and increased skin hydration (all p <01) in the CRM-treated than untreated area. A significantly higher level of ceramide (p <05) and a trend toward increased water content was observed with Raman in the SC for CRM than for the control. There were no related AEs. Conclusion: Skin barrier function and hydration were significantly improved after CRM treatment.

KW - Atopic dermatitis

KW - Ceramides

KW - Raman spectroscopy

KW - Skin barrier

KW - Skin hydration

KW - Transepidermal water loss

UR - http://www.scopus.com/inward/record.url?scp=84875302551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875302551&partnerID=8YFLogxK

U2 - 10.3109/09546634.2012.713461

DO - 10.3109/09546634.2012.713461

M3 - Article

VL - 24

SP - 122

EP - 125

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 2

ER -